Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-041021
Filing Date
2024-09-20
Accepted
2024-09-20 16:05:53
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 spyretherapeutics-resalesx3.htm S-3 339447
2 EX-FILING FEES exhibit107-resalesx3.htm EX-FILING FEES 25678
3 EX-5.1 exhibit51-resalesx3.htm EX-5.1 14506
4 EX-23.1 exhibit231-resalesx3.htm EX-23.1 1923
5 EX-23.2 exhibit232-resalesx3.htm EX-23.2 1948
6 gibsondunn.jpg GRAPHIC 75214
7 prospectuscover1a.jpg GRAPHIC 5111
  Complete submission text file 0001628280-24-041021.txt   495451
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282252 | Film No.: 241313417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)